Edwards Lifesciences (EW) Inventory (2009 - 2026)

Edwards Lifesciences' Inventory history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Inventory changed 0.46% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (changed 0.46% YoY), while the FY2025 annual figure was $1.1 billion, up 3.63% from the prior year.
• Inventory was $1.1 billion for Q1 2026 at Edwards Lifesciences, down from $1.1 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $1.2 billion in Q1 2024 to a low of $730.6 million in Q1 2022.
• Historically, Inventory has averaged $999.9 million across 5 years, with a median of $1.0 billion in 2023.
• The sharpest annual moves came in 2023 and 2025: Inventory surged 36.24% in 2023, then retreated 7.74% in 2025.
• A 5-year view of Inventory shows it stood at $875.5 million in 2022, then gained by 3.2% to $903.5 million in 2023, then gained by 20.28% to $1.1 billion in 2024, then advanced by 3.63% to $1.1 billion in 2025, then declined by 0.64% to $1.1 billion in 2026.
• The last three Inventory figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.